Clinical Effectiveness and Safety of SHR-A1811 in Chinese Patients With HER2-Altered Advanced/Metastatic Non-small Cell Lung Cancer: a Prospective, Observational Study
NCT07516015 · NOT YET RECRUITING · N/A
We track 1 ClinicalTrials.gov studies led by Nanjing Tianyinshan Hospital. The portfolio skews toward N/A (1 trials).
1 clinical trials sponsored by Nanjing Tianyinshan Hospital.
| Phase | Trials | Distribution |
|---|---|---|
| N/A | 1 | 100% |
Nanjing Tianyinshan Hospital currently sponsors 1 clinical trials tracked on ReadTheTrial. These span N/A.
Nanjing Tianyinshan Hospital conducts research across multiple therapeutic areas. Browse the trial listings for details.
Check the trial listings below for current recruitment status. Trial recruitment status can change frequently.